Dave Caspers - 01 Apr 2026 Form 4 Insider Report for Ardent Health, Inc. (ARDT)

Reporting relationship: Chief Operating Officer
Issuer ticker: ARDT
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2026, 16:27:10 UTC
Prior SEC filing: 02 Apr 2025
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Stephen C. Petrovich, Attorney-in-Fact

Key filing fact

Dave Caspers filed Form 4 for Ardent Health, Inc. (ARDT) on 02 Apr 2026.

Key facts

This page summarizes Dave Caspers's Form 4 filing for Ardent Health, Inc. (ARDT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Apr 2026, 16:27.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001995952 Primary reporting owner

Caspers Dave

Relationship: Chief Operating Officer
Address: 340 SEVEN SPRINGS WAY, SUITE 100, BRENTWOOD
Signature: /s/ Stephen C. Petrovich, Attorney-in-Fact
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARDT transaction

Common Stock

Tax liability

Transaction value
Shares: -2,684
Change %: -7%
Price: $8.67^*
Shares after: 35,604
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1, F2

ARDT transaction

Common Stock

Award

Transaction value
Shares: +35,673
Change %: +100%
Price: $0.000000^*
Shares after: 71,277
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

Footnote F2

Represents the closing price of the common stock of the Issuer on April 1, 2026.

Footnote F3

Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date